Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Poliomyelitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan
Conditions: Polio;   Polio Sero Conversion;   Polio Sero Prevalence;   Immunization Coverage
Interventions: Behavioral: Enhanced Community mobilization;   Biological: Combined Oral Polio Vaccine and Inject able Polio Vaccine during SIA
2 Unknown  Study of Mental Fatigue in Polio Survivors
Condition: Post-Poliomyelitis Syndrome
Intervention:
3 Recruiting L-Citrulline in Patients With Post-Polio Syndrome
Condition: Post-Polio Syndrome
Interventions: Drug: 15g L-citrulline daily p.o.;   Drug: Placebo
4 Recruiting Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition: Post-polio Syndrome
Interventions: Biological: Flebogamma 5% DIF;   Other: Placebo
5 Recruiting Safety and Immunogenicity of IPOVAC in Young Children
Condition: Poliomyelitis
Interventions: Biological: IMOVAC-POLIO;   Biological: IPOVAC 1.5:5:5;   Biological: IPOVAC, 3:10:10;   Biological: IPOVAC, 6:20:20
6 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania
Condition: Poliomyelitis
Intervention: Biological: Sabin mOPV2
7 Not yet recruiting A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
Condition: Poliomyelitis
Intervention: Biological: Oral Polio Vaccine
8 Recruiting Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Infanrix hexa;   Drug: Prevnar13
9 Recruiting Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Conditions: Spinal Cord Injuries;   Poliomyelitis;   Post-polio Syndrome;   Arthritis;   Lower Motor Neurone Lesion
Interventions: Device: C-brace;   Device: Stance control orthosis
10 Not yet recruiting Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Diphtheria;   Hepatitis B;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Tetanus;   Poliomyelitis
Intervention: Biological: Infanrix hexa
11 Recruiting Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type b
Intervention: Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)
12 Unknown  Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns
Condition: Poliomyelitis
Interventions: Biological: Trivalent OPV Birmex;   Biological: Trivalent OPV Sanofi Pasteur
13 Recruiting A Clinical Study Comparing Safety and Immunogenicity of Bivalent Oral Polio Vaccine (bOPV) of Bilthoven Biologicals (BBio) With a Licensed bOPV
Condition: Immune Response to Oral Polio Vaccine
Interventions: Biological: Part 1 study - BBio bOPV;   Biological: Part 2 study - BBio bOPV Lot 1;   Biological: Part 2 study - BBio bOPV Lot 2;   Biological: Part 2 study - BBio bOPV Lot 3;   Biological: Part 2 study - Licensed bOPV;   Biological: Part 1 study - Licensed bOPV
14 Recruiting Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study
Condition: Poliomyelitis
Interventions: Biological: IPV at 14 and 22 weeks of age, Rotarix;   Biological: IPV at 14 and 22 weeks of age, RotaTeq;   Biological: IPV at 14 and fIPV at 22 weeks, Rotarix;   Biological: IPV at 14 and fIPV at 22 weeks, RotaTeq;   Biological: IPV at 6 and fIPV at 22 weeks, Rotarix;   Biological: IPV at 6 and fIPV at 22 weeks, RotaTeq;   Biological: fIPV at 6-14-22 weeks of age, Rotarix;   Biological: fIPV at 6-14-22 weeks of age, RotaTeq
15 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
16 Recruiting Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
Conditions: Muscle Injury;   Nerve Injury;   Poliomyelitis;   Leprosy;   Cerebral Palsy
Interventions: Procedure: Interosseous route of TPTT;   Procedure: Extra membranous route of TPTT
17 Recruiting EnhanceWellness for Individuals With Long-Term Physical Disabilities
Conditions: Multiple Sclerosis;   Muscular Dystrophy;   Post-polio Syndrome;   Spinal Cord Injury
Intervention: Behavioral: EnhanceWellness
18 Recruiting Clinical Trial of a Serious Game for Individuals With SCI/D
Conditions: Spinal Cord Injury;   Spinal Cord Involvement;   Spina Bifida;   Transverse Myelitis;   Polio and Post-polio Syndrome;   Syringomyelia;   Spinal Stenosis;   Spinal Neoplasms;   Spinal Cord Diseases
Intervention: Behavioral: SCI Hard
19 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
20 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children
Condition: Adverse Event Following Immunisation
Intervention: Biological: SABIN monovalent OPV2

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years